BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 19175555)

  • 1. Blood donor deferral in Minas Gerais State, Brazil: blood centers as sentinels of urban population health.
    Di Lorenzo Oliveira C; Loureiro F; de Bastos MR; Proietti FA; Carneiro-Proietti AB
    Transfusion; 2009 May; 49(5):851-7. PubMed ID: 19175555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying losses to the donated blood supply due to donor deferral and miscollection.
    Custer B; Johnson ES; Sullivan SD; Hazlet TK; Ramsey SD; Hirschler NV; Murphy EL; Busch MP
    Transfusion; 2004 Oct; 44(10):1417-26. PubMed ID: 15383013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of blood donor deferral characteristics in Delhi, India.
    Bahadur S; Jain S; Goel RK; Pahuja S; Jain M
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):1087-91. PubMed ID: 19842393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferral patterns of voluntary blood donors at the National Blood Transfusion Service, North East Zonal Centre, Maiduguri.
    Kagu MB; Ahmed SG; Bashir MA; Malah MB; Usoro A; Gimba I; Babakura Y; Elisha J
    Afr J Med Med Sci; 2010 Jun; 39(2):119-25. PubMed ID: 21117408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole blood donor deferral rate and characteristics of the Turkish population.
    Arslan O
    Transfus Med; 2007 Oct; 17(5):379-83. PubMed ID: 17725552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical analysis of anaemia deferral in blood donor candidates: the individual in the population perspective.
    Oliveira CD; Martins G; Custer B; Proietti FA; Carneiro-Proietti AB; César CC
    Transfus Med; 2011 Dec; 21(6):371-7. PubMed ID: 22032634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
    Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
    Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the meaning of permanent deferral for blood donors.
    Whittaker S; Carter N; Arnold E; Shehata N; Webert KE; Distefano L; Heddle NM
    Transfusion; 2008 Jan; 48(1):64-72. PubMed ID: 17894793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service.
    Charles KS; Hughes P; Gadd R; Bodkyn CJ; Rodriguez M
    Transfus Med; 2010 Feb; 20(1):11-4. PubMed ID: 19788640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
    de Almeida Neto C; McFarland W; Murphy EL; Chen S; Nogueira FA; Mendrone A; Salles NA; Chamone DA; Sabino EC
    Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood donor deferral pattern in Iran.
    Birjandi F; Gharehbaghian A; Delavari A; Rezaie N; Maghsudlu M
    Arch Iran Med; 2013 Nov; 16(11):657-60. PubMed ID: 24206408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The consequences of temporary deferral on future whole blood donation.
    Custer B; Chinn A; Hirschler NV; Busch MP; Murphy EL
    Transfusion; 2007 Aug; 47(8):1514-23. PubMed ID: 17655597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of blood donor deferral in Japan: characteristics and reasons.
    Ngoma AM; Goto A; Sawamura Y; Nollet KE; Ohto H; Yasumura S
    Transfus Apher Sci; 2013 Dec; 49(3):655-60. PubMed ID: 23891317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a prediction model for low hemoglobin deferral in a large cohort of whole blood donors.
    Baart AM; de Kort WL; Atsma F; Moons KG; Vergouwe Y
    Transfusion; 2012 Dec; 52(12):2559-69. PubMed ID: 22519683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of e-mail in acquiring and retaining whole-blood donors: a comparative analysis of the Puget Sound Blood Center donor e-mail communication program.
    Geyer ME
    Transfusion; 2005 Dec; 45(12):1957-64. PubMed ID: 16371050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia screening in potential female blood donors: comparison of two different quantitative methods.
    Mendrone A; Sabino EC; Sampaio L; Neto CA; Schreiber GB; Chamone Dde A; Dorlhiac-Llacer PE
    Transfusion; 2009 Apr; 49(4):662-8. PubMed ID: 19171005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies.
    O'brien SF; Chiavetta JA; Goldman M; Fan W; Nair RC; Sher GD; Vamvakas EC
    Transfusion; 2006 Mar; 46(3):461-8. PubMed ID: 16533291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.